Structural insights into the Middle East respiratory syndrome coronavirus 4a protein and its dsRNA binding mechanism

[1]  Lisa E. Gralinski,et al.  Broad-spectrum antiviral GS-5734 inhibits both epidemic and zoonotic coronaviruses , 2017, Science Translational Medicine.

[2]  Rua'a A. Al-Aqtash,et al.  Computational modeling of the bat HKU4 coronavirus 3CLpro inhibitors as a tool for the development of antivirals against the emerging Middle East respiratory syndrome (MERS) coronavirus , 2017, Journal of molecular recognition : JMR.

[3]  Jiun-Jie Shie,et al.  Identification and evaluation of potent Middle East respiratory syndrome coronavirus (MERS-CoV) 3CLPro inhibitors , 2017, Antiviral Research.

[4]  G. Gao,et al.  The recombinant N-terminal domain of spike proteins is a potential vaccine against Middle East respiratory syndrome coronavirus (MERS-CoV) infection , 2016, Vaccine.

[5]  H. Feldmann,et al.  Alisporivir inhibits MERS- and SARS-coronavirus replication in cell culture, but not SARS-coronavirus infection in a mouse model , 2016, Virus Research.

[6]  N. Alharbi.  Vaccines against Middle East respiratory syndrome coronavirus for humans and camels , 2016, Reviews in medical virology.

[7]  S. Perlman,et al.  Introduction of neutralizing immunogenicity index to the rational design of MERS coronavirus subunit vaccines , 2016, Nature Communications.

[8]  Yufei Wang,et al.  A recombinant receptor-binding domain of MERS-CoV in trimeric form protects human dipeptidyl peptidase 4 (hDPP4) transgenic mice from MERS-CoV infection , 2016, Virology.

[9]  R. E. Wiley,et al.  Toward Developing a Preventive MERS-CoV Vaccine—Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14–15, 2015 , 2016, Emerging infectious diseases.

[10]  Ben M. Webb,et al.  Comparative Protein Structure Modeling Using MODELLER , 2016, Current protocols in bioinformatics.

[11]  Shibo Jiang,et al.  Vaccines for the prevention against the threat of MERS-CoV , 2016, Expert review of vaccines.

[12]  Julie Clark,et al.  Open Source Drug Discovery: Highly Potent Antimalarial Compounds Derived from the Tres Cantos Arylpyrroles , 2016, ACS central science.

[13]  Sangdun Choi,et al.  In silico mechanistic analysis of IRF3 inactivation and high-risk HPV E6 species-dependent drug response , 2015, Scientific Reports.

[14]  Sangdun Choi,et al.  Middle East respiratory syndrome coronavirus: transmission, virology and therapeutic targeting to aid in outbreak control , 2015, Experimental & Molecular Medicine.

[15]  Martin Fechner,et al.  Best bang for your buck: GPU nodes for GROMACS biomolecular simulations , 2015, J. Comput. Chem..

[16]  A. Iwasaki,et al.  Control of adaptive immunity by the innate immune system , 2015, Nature Immunology.

[17]  S. Shalhoub,et al.  Successful recovery of MERS CoV pneumonia in a patient with acquired immunodeficiency syndrome: A case report , 2014, Journal of Clinical Virology.

[18]  D. Marc.  Influenza virus non-structural protein NS1: interferon antagonism and beyond. , 2014, The Journal of general virology.

[19]  S. Upadhyay.  Dynamics of Gal80p in the Gal80p-Gal3p complex differ significantly from the dynamics in the Gal80p-Gal1p complex: implications for the higher specificity of Gal3p. , 2014, Molecular bioSystems.

[20]  Rajendra Kumar,et al.  g_mmpbsa - A GROMACS Tool for High-Throughput MM-PBSA Calculations , 2014, J. Chem. Inf. Model..

[21]  Krystal L. Matthews,et al.  The ORF4b-encoded accessory proteins of Middle East respiratory syndrome coronavirus and two related bat coronaviruses localize to the nucleus and inhibit innate immune signalling. , 2014, The Journal of general virology.

[22]  K. Yuen,et al.  Middle East Respiratory Syndrome Coronavirus 4a Protein Is a Double-Stranded RNA-Binding Protein That Suppresses PACT-Induced Activation of RIG-I and MDA5 in the Innate Antiviral Response , 2014, Journal of Virology.

[23]  Charles C. David,et al.  Principal component analysis: a method for determining the essential dynamics of proteins. , 2014, Methods in molecular biology.

[24]  Yang Yang,et al.  The structural and accessory proteins M, ORF 4a, ORF 4b, and ORF 5 of Middle East respiratory syndrome coronavirus (MERS-CoV) are potent interferon antagonists , 2013, Protein & Cell.

[25]  Yang Zhang,et al.  Protein-ligand binding site recognition using complementary binding-specific substructure comparison and sequence profile alignment , 2013, Bioinform..

[26]  E. Tramontano,et al.  Strategies of highly pathogenic RNA viruses to block dsRNA detection by RIG-I-like receptors: Hide, mask, hit , 2013, Antiviral Research.

[27]  F. Weber,et al.  Middle East Respiratory Syndrome Coronavirus Accessory Protein 4a Is a Type I Interferon Antagonist , 2013, Journal of Virology.

[28]  M. Frieman,et al.  Emergence of the Middle East Respiratory Syndrome Coronavirus , 2013, PLoS pathogens.

[29]  C. Reis e Sousa,et al.  Cytosolic Sensing of Viruses , 2013, Immunity.

[30]  Lisa E. Gralinski,et al.  Cell Host Response to Infection with Novel Human Coronavirus EMC Predicts Potential Antivirals and Important Differences with SARS Coronavirus , 2013, mBio.

[31]  Y. Guan,et al.  Tropism of and Innate Immune Responses to the Novel Human Betacoronavirus Lineage C Virus in Human Ex Vivo Respiratory Organ Cultures , 2013, Journal of Virology.

[32]  Peter M. Kasson,et al.  GROMACS 4.5: a high-throughput and highly parallel open source molecular simulation toolkit , 2013, Bioinform..

[33]  Christian Drosten,et al.  Dipeptidyl peptidase 4 is a functional receptor for the emerging human coronavirus-EMC , 2013, Nature.

[34]  Markus Eickmann,et al.  Human Cell Tropism and Innate Immune System Interactions of Human Respiratory Coronavirus EMC Compared to Those of Severe Acute Respiratory Syndrome Coronavirus , 2013, Journal of Virology.

[35]  R. Geffers,et al.  Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic Potential , 2013, mBio.

[36]  M. Buchmeier,et al.  Human Coronavirus EMC Does Not Require the SARS-Coronavirus Receptor and Maintains Broad Replicative Capability in Mammalian Cell Lines , 2012, mBio.

[37]  Alexander E. Gorbalenya,et al.  Genomic Characterization of a Newly Discovered Coronavirus Associated with Acute Respiratory Distress Syndrome in Humans , 2012, mBio.

[38]  F. Allain,et al.  RNA recognition by double-stranded RNA binding domains: a matter of shape and sequence , 2012, Cellular and Molecular Life Sciences.

[39]  Holger Gohlke,et al.  MMPBSA.py: An Efficient Program for End-State Free Energy Calculations. , 2012, Journal of chemical theory and computation.

[40]  H. Gohlke,et al.  Free Energy Calculations by the Molecular Mechanics Poisson−Boltzmann Surface Area Method , 2012, Molecular informatics.

[41]  Mohammad Hassan Khalid,et al.  Homology modeling of an antifungal metabolite plipastatin synthase from the Bacillus subtilis 168 , 2011, Bioinformation.

[42]  Tingjun Hou,et al.  Assessing the performance of the molecular mechanics/Poisson Boltzmann surface area and molecular mechanics/generalized Born surface area methods. II. The accuracy of ranking poses generated from docking , 2011, J. Comput. Chem..

[43]  Frédéric H.-T. Allain,et al.  The Solution Structure of the ADAR2 dsRBM-RNA Complex Reveals a Sequence-Specific Readout of the Minor Groove , 2010, Cell.

[44]  P. Karplus,et al.  A fresh look at the Ramachandran plot and the occurrence of standard structures in proteins , 2010, Biomolecular concepts.

[45]  A. Fernández-Sesma,et al.  Inhibition of the Type I Interferon Response in Human Dendritic Cells by Dengue Virus Infection Requires a Catalytically Active NS2B3 Complex , 2010, Journal of Virology.

[46]  Christian Holm,et al.  Optimizing working parameters of the smooth particle mesh Ewald algorithm in terms of accuracy and efficiency. , 2010, The Journal of chemical physics.

[47]  Morten Nielsen,et al.  CPHmodels-3.0—remote homology modeling using structure-guided sequence profiles , 2010, Nucleic Acids Res..

[48]  David S. Wishart,et al.  PROSESS: a protein structure evaluation suite and server , 2010, Nucleic Acids Res..

[49]  Lazaros Mavridis,et al.  HexServer: an FFT-based protein docking server powered by graphics processors , 2010, Nucleic Acids Res..

[50]  Yin Liu,et al.  Murine Coronavirus Induces Type I Interferon in Oligodendrocytes through Recognition by RIG-I and MDA5 , 2010, Journal of Virology.

[51]  Yang Zhang,et al.  I-TASSER: a unified platform for automated protein structure and function prediction , 2010, Nature Protocols.

[52]  R. Dror,et al.  Improved side-chain torsion potentials for the Amber ff99SB protein force field , 2010, Proteins.

[53]  Pascal Benkert,et al.  QMEAN server for protein model quality estimation , 2009, Nucleic Acids Res..

[54]  A. Liwo,et al.  Principal component analysis for protein folding dynamics. , 2009, Journal of molecular biology.

[55]  M. Sternberg,et al.  Protein structure prediction on the Web: a case study using the Phyre server , 2009, Nature Protocols.

[56]  Jyoti Yadav,et al.  Open Source Drug Discovery , 2008 .

[57]  Giovanni Chillemi,et al.  Thr729 in human topoisomerase I modulates anti-cancer drug resistance by altering protein domain communications as suggested by molecular dynamics simulations , 2008, Nucleic acids research.

[58]  D. Davies,et al.  Structural Basis of Toll-Like Receptor 3 Signaling with Double-Stranded RNA , 2008, Science.

[59]  Manfred J. Sippl,et al.  Thirty years of environmental health research--and growing. , 1996, Nucleic Acids Res..

[60]  Gaetano T Montelione,et al.  Evaluating protein structures determined by structural genomics consortia , 2006, Proteins.

[61]  B. Finlay,et al.  Anti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens , 2006, Cell.

[62]  S. Akira,et al.  Pathogen Recognition and Innate Immunity , 2006, Cell.

[63]  S. Perlman,et al.  Immunopathogenesis of coronavirus infections: implications for SARS , 2005, Nature Reviews Immunology.

[64]  D. Court,et al.  Intermediate states of ribonuclease III in complex with double-stranded RNA. , 2005, Structure.

[65]  Piero Fariselli,et al.  I-Mutant2.0: predicting stability changes upon mutation from the protein sequence or structure , 2005, Nucleic Acids Res..

[66]  J. Skolnick,et al.  TM-align: a protein structure alignment algorithm based on the TM-score , 2005, Nucleic acids research.

[67]  Conrad C. Huang,et al.  UCSF Chimera—A visualization system for exploratory research and analysis , 2004, J. Comput. Chem..

[68]  Flavio Seno,et al.  Geometry and symmetry presculpt the free-energy landscape of proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[69]  Luhua Lai,et al.  Structure-based method for analyzing protein–protein interfaces , 2004, Journal of molecular modeling.

[70]  A. Bond,et al.  Use of MATHEMATICA software for theoretical analysis of linear sweep voltammograms , 2004 .

[71]  Manuel C. Peitsch,et al.  SWISS-MODEL: an automated protein homology-modeling server , 2003, Nucleic Acids Res..

[72]  W. Delano.  The PyMOL Molecular Graphics System , 2002 .

[73]  Thomas L. Madden,et al.  Improving the accuracy of PSI-BLAST protein database searches with composition-based statistics and other refinements. , 2001, Nucleic acids research.

[74]  Berk Hess,et al.  LINCS: A linear constraint solver for molecular simulations , 1997, J. Comput. Chem..

[75]  E. Myers,et al.  Basic local alignment search tool. , 1990, Journal of molecular biology.